Details for: CL0000954

Cell ID: CL0000954

Cell Name: small pre-B-II cell

Description: Small pre-B-II cells are also reportedly CD10-positive, CD19-positive, CD34-negative, CD79a-positive, CD127-negative, TdT-negative, Vpre-B-negative, sIgM-negative, and sIgD-negative. Transcription factors: PU.1-positive, Ikaros-positive, E2A-positive, and PAX5-positive.

Synonyms: small pre-BII cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for small pre-B-II cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for small pre-B-II cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for small pre-B-II cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for small pre-B-II cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  small pre-B-II cell (CL0000954)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [small pre-B-II cell](/details-cell/CL0000954) is a developing B-lymphocyte progenitor characterized by a distinct immunophenotype, including expression of CD10 and CD19, and the absence of surface immunoglobulin. Molecularly, its identity is defined by a high-specificity gene expression signature dominated by fundamental cellular processes. **Overall**, the top markers highlight intense activity in chromatin organization (e.g., [H3 3B](/details-gene/3021), [H3 3A](/details-gene/3020)), RNA processing, and translation ([PABPC1](/details-gene/26986), [HNRNPA1](/details-gene/3178)), coupled with tight regulation of cell proliferation ([BTG1](/details-gene/694)). This profile is consistent with a rapidly dividing and differentiating cell undergoing critical developmental checkpoints before transitioning to an immature B cell. ## Key Characteristics and Function Analysis of the gene significance profile for the [small pre-B-II cell](/details-cell/CL0000954) reveals several core functional clusters that define its biological state. * **High Biosynthetic Activity:** The cell exhibits a strong signature of active transcription and translation. Top markers include histone variants ([H3 3B](/details-gene/3021), [H3 3A](/details-gene/3020)) and chromatin-binding proteins ([HMGB1](/details-gene/3146)), suggesting dynamic chromatin remodeling required for developmental gene expression programs. Furthermore, high-specificity markers for RNA processing and stability, such as [PABPC1](/details-gene/26986), [HNRNPA1](/details-gene/3178), and [HNRNPA2B1](/details-gene/3181), underscore a state of high protein synthesis, likely to support cell growth and the production of pre-B cell receptor components. * **Cell Cycle Regulation and Proliferation:** The transcriptome suggests a state of active but tightly controlled proliferation. The G1/S transition-associated cyclin [CCNI](/details-gene/10983) is a specific marker. Intriguingly, the anti-proliferative gene [BTG1](/details-gene/694), a known tumor suppressor, is also one of the most specific markers for this cell type ([Link](https://doi.org/10.1002/j.1460-2075.1992.tb05213.x)). This co-expression may indicate the activity of critical cell cycle checkpoints that gate the proliferative bursts characteristic of this developmental stage. * **Metabolic and Energy Production:** The energy demands of a rapidly dividing progenitor are reflected in the specific expression of genes involved in mitochondrial respiration and metabolism. These include components of the ATP synthase complex ([ATP5MG](/details-gene/10632), [ATP5MC2](/details-gene/517)) and cytochrome c oxidase ([COX1](/details-gene/4512)). Additionally, high specificity for ferritin light and heavy chain genes ([FTL](/details-gene/2512), [FTH1](/details-gene/2495)) points to a crucial role for iron metabolism, a key cofactor for cellular proliferation. * **Immune Identity and Surveillance:** The cell's lymphoid identity is affirmed by the high specificity of [B2M](/details-gene/567), an essential component of MHC class I molecules. Notably, the non-classical MHC class I gene [HLA E](/details-gene/3133) is also a top marker. [HLA E](/details-gene/3133) is primarily involved in modulating the activity of NK cells, suggesting that [small pre-B-II cells](/details-cell/CL0000954) may actively signal their "health" to the innate immune system to avoid off-target killing during their development. * **Lineage Exclusion:** The anti-markers profile robustly defines what this cell is not. The lack of specific expression for genes related to skeletal development ([BMP3](/details-gene/651)), myeloid-associated inflammatory pathways ([ALOX5](/details-gene/240), [TRAF6](/details-gene/7189)), and certain differentiated functions ([ITM2B](/details-gene/9445)) confirms its commitment to the B-lymphoid lineage and its progenitor status. ## Clinical Significance and Contextual Roles The gene signature of the [small pre-B-II cell](/details-cell/CL0000954) provides insight into its potential role in hematological malignancies. As a highly proliferative progenitor, this cell type represents a critical stage where developmental processes can be subverted to drive oncogenesis. The high specific expression of [BTG1](/details-gene/694) is particularly relevant, as its deletion or downregulation is a recurrent event in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). This suggests that [BTG1](/details-gene/694) functions as a crucial native tumor suppressor that must be inactivated for malignant transformation to proceed at this stage. Similarly, while mutations are more common in myeloid leukemia, the high expression of [NPM1](/details-gene/4869), a key regulator of ribosome biogenesis and genomic stability, highlights its importance in normal B-cell development; its dysregulation could contribute to lymphomagenesis. The overall profile of high transcriptional activity ([HNRNPA1](/details-gene/3178)), rapid proliferation, and active metabolism indicates that this cell stage may be particularly vulnerable to mutations that disrupt these core processes, leading to uncontrolled growth and developmental arrest, hallmarks of leukemia. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The specific co-expression of the anti-proliferative factor [BTG1](/details-gene/694) with pro-growth machinery suggests it acts as a central checkpoint regulator in the [small pre-B-II cell](/details-cell/CL0000954). This protein may function to temporarily halt the cell cycle, allowing for high-fidelity rearrangement of the immunoglobulin light chain genes, a defining event of this stage, thereby preventing the propagation of cells with non-productive or oncogenic rearrangements. * **Surprising Findings:** It is counterintuitive that an anti-proliferative gene would be one of the most specific markers for a highly proliferative progenitor cell. This suggests its role is not constitutive repression but rather a finely-tuned, context-dependent regulatory function. * **Testable Questions:** Does the targeted degradation or knockout of [BTG1](/details-gene/694) in human B-cell progenitors *in vitro* result in an accumulation of cells with aberrant light chain rearrangements or increased signs of genomic instability? 2. **Hypothesis:** The specific expression of [HLA E](/details-gene/3133) by [small pre-B-II cells](/details-cell/CL0000954) represents a mechanism of innate immune evasion critical for normal B-cell development. By presenting a conserved set of peptides, [HLA E](/details-gene/3133) likely engages inhibitory receptors (e.g., NKG2A) on bone marrow-resident NK cells, providing a dominant "don't kill me" signal that protects these vital progenitors from surveillance-mediated apoptosis. * **Surprising Findings:** The prominence of a non-classical MHC molecule typically associated with NK cell interactions, rather than classical antigen presentation, points to a previously underappreciated dialogue between developing B-cells and the innate immune system. * **Testable Questions:** Using a co-culture system, does antibody-mediated blocking of the [HLA E](/details-gene/3133)-NKG2A interaction lead to increased NK cell degranulation and specific lysis of [small pre-B-II cells](/details-cell/CL0000954) compared to isotype controls?